View drug registration information details.
| Items | Registration information |
|---|
| ID | 2213 |
|---|
| No | 2213 |
|---|
| Brand Name | RANCARD XR TABLET 1000 MG |
|---|
| Ingredients | RANOLAZINE 1000 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-ALU BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 14'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | INDICATED IN ADULT AS ADD-ON THERAPY FOR THE SYMPTOMATIC TREATMENT OF PATIENTS WITH STABLE ANGINA PECTORIS WHO ARE INDADEQUATELY CONTROLLED OR INTOLERANT TO FIRSTLINE ANTI-ANGINAL THERAPIES(SUCH AS BETA BLOCKERS AND/OR CALCIUM ANTAGONIST) |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | PURPLE COLOR, OBLONG SHAPED, FILM COATED TABLETS, ENGRAVED SEARLE ON ONE SIDE AND BREAKLINE ON THE OTHER |
|---|
| Note | |
|---|
| License Owner | POUNSAB PHARMA CO.,LTD |
|---|
| Manufacturer | THE SEARLE COMPANY LIMITED |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 05 I 5510/23 |
|---|
| FDD Registration Date | 09-MAY-2023 |
|---|
| Expiry Date | 08-MAY-2026 |
|---|
Back to drug list
|
